Brett Hagen
Comptroller/Controller/Auditor chez ALLOVIR, INC.
Fortune : 60 385 $ au 30/04/2024
Postes actifs de Brett Hagen
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALLOVIR, INC. | Comptroller/Controller/Auditor | 01/01/2019 | - |
Historique de carrière de Brett Hagen
Anciens postes connus de Brett Hagen
Sociétés | Poste | Début | Fin |
---|---|---|---|
ELOXX PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/02/2018 | 01/08/2018 |
Directeur Financier/CFO | 01/02/2018 | 01/08/2018 | |
PROTEOSTASIS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 04/08/2016 | 31/12/2017 |
Directeur Financier/CFO | 10/02/2017 | 25/07/2017 | |
DNIB UNWIND INC | Comptroller/Controller/Auditor | 01/07/2014 | 01/05/2016 |
BOSTON PRIVATE FINANCIAL HOLDINGS, INC. | Directeur Financier/CFO | 01/01/2009 | 01/07/2014 |
BioProcessors Corp.
BioProcessors Corp. Electronic Equipment/InstrumentsElectronic Technology BioProcessors, Inc. provides micro-engineered solutions for the biotechnology and pharmaceutical industry. It offers biomanufacturing workflow methods and technologies that help scientists to optimize the process development. The company was founded by Andrey Zarur in October 2000 and is located in Woburn, MA. | Comptroller/Controller/Auditor | - | - |
Formation de Brett Hagen
University of Minnesota | Undergraduate Degree |
Wright State University (Ohio) | Graduate Degree |
Suffolk University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Comptroller/Controller/Auditor | 5 |
Director of Finance/CFO | 3 |
Graduate Degree | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALLOVIR, INC. | Health Technology |
ELOXX PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Boston Private Financial Holdings, Inc.
Boston Private Financial Holdings, Inc. Regional BanksFinance Boston Private Financial Holdings, Inc. engages in the provision of banking services. It operates through the Private Banking; and Wealth Management and Trust segments. The Private Banking segment offers services to privately owned businesses, private partnerships, and non-profit organizations. The Wealth Management and Trust segment offers planning-based financial strategies, wealth management, family office, financial planning, tax planning, and trust services to individuals, families, institutions, and nonprofit institutions. The company was founded on September 2, 1987 and is headquartered in Boston, MA. | Finance |
BioProcessors Corp.
BioProcessors Corp. Electronic Equipment/InstrumentsElectronic Technology BioProcessors, Inc. provides micro-engineered solutions for the biotechnology and pharmaceutical industry. It offers biomanufacturing workflow methods and technologies that help scientists to optimize the process development. The company was founded by Andrey Zarur in October 2000 and is located in Woburn, MA. | Electronic Technology |
- Bourse
- Insiders
- Brett Hagen
- Expérience